Comparative Crossover, Randomized, Open-Label Bioequivalence Study on the Bioequivalence of Two Formulations of Thioctic Acid in Healthy Volunteers

References

• Snell EE, Strong FM, Peterson WH. Growth factors for bacteria VI: Fractionation and properties of an accessory factor for lactic acid bacteria. Biochem J 1937; 31: 1789–1799
   PubMedGoogle Scholar
• Reed LJ. Multienzyme complexes. Acc Chem Res 1974; 7: 40
   Web of Science ®Google Scholar
• Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227–250
   PubMed Web of Science ®Google Scholar
• Scholich H, Murphy ME, Sies H. Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on alpha-tocopherol. Biochim Biophys Acta 1989; 1001: 256–261
   PubMed Web of Science ®Google Scholar
• Busse E, Zimmer G, Schopohl B, Kornhuber B. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung 1992; 42: 829–831
   PubMed Web of Science ®Google Scholar
• Kagan VE, Serbinova EA, Koynova GM, Kitanova SA, Tyurin VA, Stoytchev TS, Quinn PJ, Packer L. Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes. Free Radic Biol Med 1990; 9: 117–126
   PubMed Web of Science ®Google Scholar
• Jorg J, Metz F, Scharafinski H. Drug treatment of diabetic polyneuropathy with alpha-lipoic acid or vitamin B preparations. A clinical and neurophysiologic study. Nervenarzt 1988; 59: 36–44
   PubMed Web of Science ®Google Scholar
• Ziegler D, Mayer P, Muehlen H, Gries FA. Effekte einer Therapie mit alpha- Liponsaeure gegenueber Vitamin B1 bei der diabetischen Neuropathie. Diabetes Stoffw 1993; 2: 443
   Google Scholar
• Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A three-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995; 38: 1425–1433
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 1997; 40: 647–653
   PubMed Web of Science ®Google Scholar
• Ziegler D, Schatz H, Conrad F, et al. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A four-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 1997; 20: 369–373
   PubMed Web of Science ®Google Scholar
• Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 1997; 46: S62–S66
   PubMed Web of Science ®Google Scholar
• Borcea V, Nourooz-Zadeh J, Wolff SP, et al. Alpha-lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med 1999; 26: 1495–1500
   PubMed Web of Science ®Google Scholar
• Haak ES, Usadel KH, Kohleisen M, et al. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy. Microvasc Res 1999; 58: 28–34
   PubMed Web of Science ®Google Scholar
• Rehman A, Nourooz-Zadeh J, Moller W, et al. Increased oxidative damage to all DNA bases in patients with type II diabetes. FEBS Lett 1999; 448: 120–122
   PubMed Web of Science ®Google Scholar
• Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A seven-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999; 22: 1296–1301
   PubMed Web of Science ®Google Scholar
• Gleiter CH, Schung BS, Hermann R, Elze M, Blume HH, Guntert-Remy U. Influence of food intake on the bioavailability of thioctic acid enantiomers. Eur J Clin Pharmacaol 1996; 50: 513–514
   PubMed Web of Science ®Google Scholar
• Hermann R, Niebch G, Borbe HO, et al. Enantioselective pharmacokinetics and bioavailability of different racemic alpha-lipoic acid formulations in healthy volunteers. Eur J Clin Pharmacol Sci 1996; 4: 167
   Web of Science ®Google Scholar
• Teichert J, Kern J, Tritschler HJ, Ulrich H, Preiss R. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther 1998; 36: 625–628
   PubMed Web of Science ®Google Scholar
• Breithaupt-Grögler K, Niebch G, Schneider E, et al. Dose-proportionality of oral thioctic acid—coincidence of assessments via pooled plasma and individual data. Eur J Clin Pharmacol Sci 1999; 8: 57–65
   PubMed Web of Science ®Google Scholar
• http://www.idi.it/ric/ce/helsinki.pdf, World Medical Association Declaration of Helsinki. 52nd WMA General Assembly, Edinburgh, Scotland, October 2000. Available at:
   Google Scholar
• Chen J, Jiang W, Cai J, Tao W, Gao X, Jiang X. Quantification of lipoic acid in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci Sep, 2005; 824: 249–257
   PubMed Web of Science ®Google Scholar
• Hodges JR, Lehmann EL. Annals of Mathematical Statistics 1963; 34: 598–611
   Google Scholar
• Phillips KF. Power of the two one-sided tests procedure in bioequivalence. Journal Pharmacokinet Biopharm 1990; 18(2)137–144
   PubMedGoogle Scholar
• Sauter R, Steinijans VW, Diletti E, Bohm A, Schulz HU. Presentation of results from bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 1992; 30(7)233–256
   PubMedGoogle Scholar
• Chow SC, Liu JP. Desigend and Analysis of Bioavailability and Bioequivalence Studies. Marcell Dekker Inc, New York 1992
   Google Scholar
• Tschudi MR, Luscher TF. Nitric oxide: The endogenous nitrate in the cardiovascular system. Herz 1996; 21: 50–60
   PubMedGoogle Scholar
• Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916–1923
   PubMed Web of Science ®Google Scholar
• Noll G, Tschudi M, Nava E, Luscher TF. Endothelium and high blood pressure. Int J Microcirc Clin Exp 1997; 17: 273–279
   PubMedGoogle Scholar
• Pechanova O, Kashiba M, Inoue M. Role of glutathione in stabilization of nitric oxide during hypertension developed by inhibition of nitric oxide synthase in the rat. Jpn J Pharmacol 1999; 81: 223–229
   PubMedGoogle Scholar
• Zicha J, Dobesova Z, Kunes J. Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: The possible role of superoxide anions. J Hypertens 2001; 19: 247–254
   PubMed Web of Science ®Google Scholar
• Kunes J, Hojna S, Kadlecova M, Dobesova Z, Rauchova H, Vokurkova M, Loukotova J, Pechanova O, Zicha J. Altered balance of vasoactive systems in experimental hypertension: The role of relative NO deficiency. Physiol Res 2004; 53: S23–S34
   PubMed Web of Science ®Google Scholar
• Pechanova O, Rezzani R, Babal P, Bernatova I, Andriantsitohaina R. Beneficial effects of provinols: Cardiovascular system and kidney. Physiol Res 2006; 55: S17–S30
   PubMed Web of Science ®Google Scholar
• de Champlain J, Wu R, Girouard H, Karas M, El Midaoui A, Laplante MA, Wu L. Oxidative stress in hypertension. Clin Exp Hypertens 2004; 26: 593–601
   PubMed Web of Science ®Google Scholar
• Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001; 38: 606–611
   PubMed Web of Science ®Google Scholar
• Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, Faraci FM, Heistad DD. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: Role of heparin-binding domain. Circ Res 2003; 92: 461–468
   PubMed Web of Science ®Google Scholar
• Kojsova S, Jendekova L, Zicha J, Kunes J, Andriantsitohaina R, Pechanova O. The effect of different antioxidants on nitric oxide production in hypertensive rats. Physiol Res 2006; 55: S3–S16
   PubMed Web of Science ®Google Scholar
• Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr Metab Cardiovasc Dis 2000; 10: 339–346
   PubMed Web of Science ®Google Scholar
• Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens 2000; 18: 567–573
   PubMed Web of Science ®Google Scholar
• Vasdev S, Gill V, Longerich L, Parai S, Gadag V. Salt-induced hypertension in WKY rats: Prevention by alpha-lipoic acid supplementation. Mol Cell Biochem 2003; 254: 319–326
   PubMed Web of Science ®Google Scholar
• Wollin SD, Jones PJ. Alpha-lipoic acid and cardiovascular disease. J Nutr Nov, 2003; 133: 3327–3330
   PubMed Web of Science ®Google Scholar
• Holmquist L, Stuchbury G, Berbaum K, Muscat S, Young S, Hager K, Engel J, Munch G. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther Jan, 2007; 113: 154–164
   PubMed Web of Science ®Google Scholar
• Pershadsingh HA. Alpha-lipoic acid: Physiologic mechanisms and indications for the treatment of metabolic syndrome. Expert Opin Investig Drugs Mar, 2007; 16: 291–302
   PubMed Web of Science ®Google Scholar